AASCIT - Journal - All Issues

ISSN: 2375-3935

American Journal of Food Science and Nutrition

The Journal

Manuscript Information

Lycosome Technology: Advances and Perspectives

American Journal of Food Science and Nutrition
Vol.3 , No. 1, Publication Date: Mar. 14, 2016, Page: 18-23

2744 Views Since March 15, 2016, 1312 Downloads Since Mar. 15, 2016

Paper in PDF (569K)

Paper in Html

Follow on

Authors

[1]	Ivan M. Petyaev, Lycotec Ltd, Granta Park Campus, Cambridge, United Kingdom.

Abstract

Lycosome technology represents a new development in the modern biotechnology directed at improvement of bioavailability of nutraceuticals and pharmaceuticals as well as their organ-specific delivery. Lycosome technology exemplifies a nano-microencapsulation methodology using unique physicochemical properties of lycopene as an organic compound. Lycopene is a symmetrical non-polar tetraterpene compound containing 8 isoprene units with 13 double bonds essential for its antioxidant activity. Lycopene gains polarity and ability to interact with phospholipids upon cis-isomerization caused by heat, light exposure and pH changes. It promotes the development of thermodynamically stable and highly rigid lycopene-phospholipid biofilms suitable for coating and microencapsulation of different amphiphilic compounds and finally formation of lycosomes – nano-microdimensional particles with partial resistance to gut environment. The lycosome particles are composed of external layer and internal domain. The internal domain contains a bioactive compound of interest which needs to be delivered and distributed in the human body. It is protected by external layer containing lycopene, a hydrophobic carotenoid used as a core-forming substance. Moreover, external layer contains an amphiphilic phospholipid (phosphatydilcholine) serving as a chaperone for lycopene, and emulsifying as well as hydrophilyzing agent. Different regimens of microemulsification modus operandi which involves spray drying, ultrasound, supercritical CO₂ fusion, and other physical factors allow to obtain various lycosome formulations of nutraceuticals and pharmaceuticals as well as functional food products useful in prevention and management of cardiovascular disease and type 2 diabetes mellitus. Moreover, lycosome technology can be used for production of fortified food products for example functional dark chocolate, margarine and butter.

Keywords

Lycosomes, Lycopene, Technology, Functional Food

Reference

[01]	Censi R, Di Martino P. Polymorph Impact on the Bioavailability and Stability of Poorly Soluble Drugs. Molecules. 2015 Oct 15; 20(10): 18759-76.
[02]	Schultheiss, N.; Newman, A. Pharmaceutical co-crystals and their physicochemical properties. Cryst. Growth Des. 2009, 9, 2950–2967.
[03]	Petyaev IM. Lycopene deficiency in ageing and cardiovascular disease. Oxidative medicine and cellular longevity. 2016, in press.
[04]	Borel P, Desmarchelier C, Nowicki M, Bott R. Lycopene bioavailability is associated with a combination of genetic variants. Free Radic Biol Med. 2015 Jun; 83: 238-44.
[05]	Gao, L.; Zhang, D.; Chen, M. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J. Nanopart. Res. 2008, 10, 845–862.
[06]	Honda M, Igami H, Kawana T, Hayashi K, Takehara M, Inoue Y, Kitamura C. Photosensitized E/Z isomerization of (all-E)-lycopene aiming at practical applications. J Agric Food Chem. 2014 Nov 26; 62(47): 11353-6.
[07]	Honda M, Takahashi N, Kuwa T, Takehara M, Inoue Y, Kumagai T. Spectral characterisation of Z-isomers of lycopene formed during heat treatment and solvent effects on the E/Z isomerisation process. Food Chem. 2015 Mar 15; 171: 323-9.
[08]	Takehara M, Nishimura M, Kuwa T, Inoue Y, Kitamura C, Kumagai T, Honda M. Characterization and thermal isomerization of (all-E)-lycopene. J Agric Food Chem. 2014 Jan 8; 62(1): 264-9.
[09]	Wisniewska A, Widomska J, Subczynski W. Carotenoid–membrane interactions in liposomes: effect of dipolar, monopolar, and nonpolar carotenoids. Acta Bioch Polon. 2006, March 3, 53 (3): 475–484.
[10]	Blum A, Merei M, Karem A, Blum N, Ben-Arzi S, Wirsansky I, Khazim K. Effects of tomatoes on the lipid profile. Clin Invest Med. 2006 Oct; 29(5): 298-300.
[11]	Bashmakov YK, Assaad-Khalil SH, Abou Seif M, Udumyan R, Megallaa M, Rohoma KH, Zeitoun M, Petyaev IM. Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients. ISRN Endocrinol. 2014 Feb 20; 2014: 816307. Supplement in the “World Biomedical Frontiers” (May, 2014) ISSN: 2328-0166.
[12]	Petyaev IM. Carotenoid particles and uses thereof. August 2012, WO 2012/104576. International application number PCT/GD2012/00075.
[13]	Petyaev IM, Dovgalevsky PY, Chalyk NE, Klochkov V, Kyle NH. Reduction in blood pressure and serum lipids by lycosome formulation of dark chocolate and lycopene in prehypertension. Food Sci Nutr. 2014 Nov; 2(6): 744-50.
[14]	Fernando E, Razak F, Lear SA, Anand SS. Cardiovascular Disease in South Asian Migrants. Can J Cardiol. 2015 Sep; 31(9): 1139-50.
[15]	Petyaev IM. Improvement of hepatic bioavailability as a new step for the future of statin. Arch Med Sci. 2015 Apr 25; 11(2): 406-10.
[16]	Sirtori CR. The pharmacology of statins. Pharmacol Res. 2014 Oct; 88: 3-11.
[17]	Mignone LE, Wu T, Horowitz M, Rayner CK. Whey protein: The "whey" forward for treatment of type 2 diabetes? World J Diabetes. 2015 Oct 25; 6(14): 1274-84.
[18]	Petyaev IM, Dovgalevsky PY, Klochkov VA, Chalyk NE, Kyle N. Whey protein lycosome formulation improves vascular functions and plasma lipids with reduction of markers of inflammation and oxidative stress in prehypertension. Scientific World Journal. 2012; 2012: 269476.
[19]	Lobstein T, Jackson-Leach R, Moodie ML, Hall KD, Gortmaker SL, Swinburn BA, James WP, Wang Y, McPherson K. Child and adolescent obesity: part of a bigger picture. Lancet. 2015 Jun 20; 385(9986): 2510-20.
[20]	Samuel-Hodge CD, Johnson CM, Braxton DF, Lackey M. Effectiveness of Diabetes Prevention Program translations among African Americans. Obes Rev. 2014 Oct; 15 Suppl 4: 107-24.
[21]	Bashmakov YK, Assaad-Khalil S, Petyaev IM. Resveratrol may be beneficial in treatment of diabetic foot syndrome. Med Hypotheses. 2011 Sep; 77(3): 364-7.
[22]	Bashmakov YK, Assaad-Khalil SH, Abou Seif M, Udumyan R, Megallaa M, Rohoma KH, Zeitoun M, Petyaev IM. Resveratrol promotes foot ulcer size reduction in type 2 diabetes patients. ISRN Endocrinol. 2014 Feb 20; 2014: 816307.
[23]	Şentürk T, Günay Ş. The mysterious light of dark chocolate. Turk Kardiyol Dern Ars. 2015 Mar; 43(2): 199-207.
[24]	Haber SL, Gallus K. Effects of dark chocolate on blood pressure in patients with hypertension. Am J Health Syst Pharm. 2012 Aug 1; 69 (15): 1287-97.